Product Images Oxtellar Xr

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 4 images provide visual information about the product associated with Oxtellar Xr NDC 17772-121 by Supernus Pharmaceuticals, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Chemical Structure - oxtellar xr 01

Chemical Structure - oxtellar xr 01

Package Label - Principal Display Panel - 150 mg TRADENAME 5-Count Blister Pack - oxtellar xr 02

Package Label - Principal Display Panel - 150 mg TRADENAME 5-Count Blister Pack - oxtellar xr 02

This is a description of Oxtellar XR, which is a medication that comes in the form of extended-release tablets. It is a once-daily drug used to treat seizures caused by epilepsy. The tablets come in a bottle of 100 pieces and should be stored in a cool, dry place away from light and moisture. The pharmacist should dispense the accompanying medication guide to each patient. The tablets should not be chewed, cut, or crushed and should be swallowed whole. The manufacturer of the drug is Patheon Inc. It is made for distribution in the USA by Supernus Pharmaceuticals, Inc.*

Package Label - Principal Display Panel - 150 mg TRADENAME 5-Count Blister Pack - Back Panels - oxtellar xr 03

Package Label - Principal Display Panel - 150 mg TRADENAME 5-Count Blister Pack - Back Panels - oxtellar xr 03

Oxtellar XR is a medication produced by Supernus for the treatment of seizures associated with epilepsy. The medication comes in the form of extended-release tablets that should be taken once daily. It is important to swallow the tablet whole and not cut, crush, or chew. The tablets are packaged with a medication guide that should be given to each patient. The medication should be stored at 25°C (77°F), with excursions between 15°C to 30°C (59°F to 86°F) and protected from light and moisture. It is manufactured by Patheon Inc in Canada and marketed by Supernus Pharmaceuticals in the USA. Oxtellar XR is a registered trademark of Supernus Pharmaceuticals.*

Package Label - Principal Display Panel - 150 mg TRADENAME 100-Count Bottle - oxtellar xr 04

Package Label - Principal Display Panel - 150 mg TRADENAME 100-Count Bottle - oxtellar xr 04

This is a description of Oxtellar XR (oxcarbazepine) extended-release tablets, made by Supernus Pharmaceuticals. The tablets come in a bottle of 100 and are to be taken once daily, swallowed whole, and not cut, crushed, or chewed. The pharmacist should dispense the accompanying 600mg to each patient. The tablets should be stored at controlled room temperature, protected from light and moisture, and kept out of reach of children. The manufacturer is Patheon Inc. in Whithy, Ontario, Canada, and the product is manufactured for Supernus Pharmaceuticals in Rockville, MD, USA. Note that the packaging insert should be consulted for additional information and prescribing guidelines.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.